Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydr o-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydr o-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders

Details for Australian Patent Application No. 2006264317 (hide)

International Classifications

Event Publications

31 January 2008 PCT application entered the National Phase

PCT publication WO2007/006003 Priority application(s): WO2007/006003

23 February 2012 Application Accepted

Published as AU-B-2006264317

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.